Our purpose was to verify some basic aspects of validation of the Unified Parkinson's Disease
Rating Scale (UPDRS). One hundred and sixtyseven Parkinson's disease (PD) patients …

We present a clinimetric assessment of the Movement Disorder Society (MDS)‐sponsored
revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS). The MDS‐UDPRS …

… Pablo Martinez-Martin received honoraria from speaking engagements at scientific meetings
of Abbvie and Teva, and from serving in a scientific advisory board of Abbvie; grants from …

Parkinson's disease (PD) is a neurodegenerative disorder that imposes an important burden
upon the patient's caregiver. This study aims at assessing caregiver burden (CB) and …

This article presents the revision process, major innovations, and clinimetric testing program
for the Movement Disorder Society (MDS)–sponsored revision of the Unified Parkinson's …

… No difference in total P was found between patients on treatment with levodopa or … was a
confounder and led to poor correlation with total P in some items such as sexual difficulties. As …

Non‐motor symptoms (NMS) in Parkinson's disease (PD) are common, significantly reduce
quality of life and at present there is no validated clinical tool to assess the progress or …

… The mean time to complete the scales differed significantly (p<0.001) and measured 8.1 (SD
1.9) minutes for the SPES/SCOPA and 15.6 (SD 3.6) minutes for the UPDRS. …

Background: Non‐motor symptoms are detrimental to health‐related quality of life (HRQoL)
of Parkinson's disease patients. In this study, the Non‐Motor Symptoms Scale (NMSS) was …

Aims: Pilot studies applying a humanoid robot (NAO), a pet robot (PARO) and a real animal (DOG)
in therapy sessions of patients with dementia in a nursing home and a day care center…